SPDR S&P Biotech ETF $XBI Shares Bought by Clal Insurance Enterprises Holdings Ltd

Clal Insurance Enterprises Holdings Ltd lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 61.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 691,000 shares of the exchange traded fund’s stock after buying an additional 263,000 shares during the period. Clal Insurance Enterprises Holdings Ltd owned approximately 1.03% of SPDR S&P Biotech ETF worth $84,254,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of XBI. AQR Capital Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after buying an additional 2,167 shares during the period. Marshall Wace LLP boosted its position in shares of SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after buying an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth about $260,000. Ameriprise Financial Inc. boosted its position in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after buying an additional 193 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $133.79 on Friday. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The business has a 50-day moving average of $132.63 and a 200-day moving average of $127.12. The company has a market capitalization of $8.54 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.